NCT05856747View on ClinicalTrials.gov

A Study to Compare Two Bioanalytical Assays for Tebipenem

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 4, 2023

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

TBP-PI-HBr

TBP-PI-HBr tablets.

Trial Locations (1)

63141

BioPharma Services, Creve Coeur

Sponsors

Lead Sponsor

Spero Therapeutics

All Listed Sponsors

lead

Spero Therapeutics

INDUSTRY

NCT05856747 - A Study to Compare Two Bioanalytical Assays for Tebipenem | Biotech Hunter | Biotech Hunter